Growth Disorders Completed Phase 3 Trials for Somatotropin (DB00052)

Also known as: Growth Disorder

IndicationStatusPhase
DBCOND0028940 (Growth Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00174421Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final HeightTreatment
NCT00191074Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short StatureTreatment